SlideShare a Scribd company logo

Methyl gene inc – product pipeline review – 2012

•Download as DOCX, PDF•
•
R
Rose088

This document summarizes a market research report on MethylGene Inc's product pipeline as of 2012. The report provides details on MethylGene's research areas and pipeline of drug candidates at various stages of clinical trials. It describes several of MethylGene's lead drug candidates, including their mechanisms of action and development progress. Tables of contents and figures are included listing the report's contents. Contact information is provided to request a sample or purchase the full report.

BusinessTechnology
1 of 4
Aarkstore.com announces, The Latest market research report is available in its vast collection: MethylGene Inc – Product Pipeline Review – 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s pharmaceuticals report, “MethylGene Inc - Product Pipeline Review - 2012” provides data on the MethylGene Inc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MethylGene Inc’s corporate website, SEC filings, investor presentations and featured press releases, both from MethylGene Inc and industry- specific third party sources, put together by Global Markets Direct’s team. Scope - MethylGene Inc - Brief MethylGene Inc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MethylGene Inc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Table of contents:
List of Tables 5 List of Figures 5 MethylGene Inc Snapshot 6 MethylGene Inc Overview 6 Key Information 6 Key Facts 6 MethylGene Inc – Research and Development Overview 7 Key Therapeutic Areas 7 MethylGene Inc – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 Pipeline Products – Combination Treatment Modalities 12 MethylGene Inc – Pipeline Products Glance 13 MethylGene Inc Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 MethylGene Inc – Early Stage Pipeline Products 15 Pre-Clinical Products/Combination Treatment Modalities 15 MethylGene Inc – Drug Profiles 16 Kinase Inhibitors Program 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 MG-516 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 MG-96077 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 MGCD-265 19 Product Description 19 Mechanism of Action 19 R&D Progress 19
MGCD-265 + Docetaxel 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 MGCD-265 + Erlotinib 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 MGCD-290 24 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 IMMUNOMEDICS, INC – Product Pipeline Review – 2012 Ipsen Inc. – Product Pipeline Review – 2012 MerLion Pharmaceuticals Pte Ltd – Product Pipeline Review – 2012 MethylGene Inc – Product Pipeline Review – 2012 Inovio Pharmaceuticals, Inc. – Product Pipeline Review – 2012
MOLOGEN AG – Product Pipeline Review – 2012 MorphoSys AG – Product Pipeline Review – 2012 Oncogenex Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Onyx Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Phytopharm Plc – Product Pipeline Review – 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com

Recommended

Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088
 

Recommended

Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Rose088
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Rose088
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Rose088
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Rose088
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Rose088
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Rose088
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Rose088
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Ambikabasa
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Rose088
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 

More Related Content

What's hot

Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Rose088
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Rose088
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Rose088
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Rose088
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Rose088
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Rose088
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Rose088
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Ambikabasa
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Rose088
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Rose088
 

What's hot (20)

Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012
 

Similar to Methyl gene inc – product pipeline review – 2012

Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Ambikabasa
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Rose088
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Rose088
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Rose088
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Rose088
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Ambikabasa
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011linda3395
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 

Similar to Methyl gene inc – product pipeline review – 2012 (17)

Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011Penile cancer pipeline review, q3 2011
Penile cancer pipeline review, q3 2011
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 

More from Rose088

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Rose088
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineRose088
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionRose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Rose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 

More from Rose088 (13)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoption
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 

Recently uploaded

Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyotictsugar
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCRashishs7044
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024Matteo Carbone
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfKhaled Al Awadi
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionMintel Group
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaoncallgirls2057
 
MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?Olivia Kresic
 
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadIslamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadAyesha Khan
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportMintel Group
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMintel Group
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis UsageNeil Kimberley
 

Recently uploaded (20)

Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyot
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
8447779800, Low rate Call girls in New Ashok Nagar Delhi NCR
 
IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024IoT Insurance Observatory: summary 2024
IoT Insurance Observatory: summary 2024
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted Version
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
 
MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?
 
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in IslamabadIslamabad Escorts | Call 03070433345 | Escort Service in Islamabad
Islamabad Escorts | Call 03070433345 | Escort Service in Islamabad
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample Report
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 Edition
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage2024 Numerator Consumer Study of Cannabis Usage
2024 Numerator Consumer Study of Cannabis Usage
 
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCREnjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
 

Methyl gene inc – product pipeline review – 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: MethylGene Inc – Product Pipeline Review – 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s pharmaceuticals report, “MethylGene Inc - Product Pipeline Review - 2012” provides data on the MethylGene Inc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MethylGene Inc’s corporate website, SEC filings, investor presentations and featured press releases, both from MethylGene Inc and industry- specific third party sources, put together by Global Markets Direct’s team. Scope - MethylGene Inc - Brief MethylGene Inc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MethylGene Inc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Table of contents:
  • 2. List of Tables 5 List of Figures 5 MethylGene Inc Snapshot 6 MethylGene Inc Overview 6 Key Information 6 Key Facts 6 MethylGene Inc – Research and Development Overview 7 Key Therapeutic Areas 7 MethylGene Inc – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 Pipeline Products – Combination Treatment Modalities 12 MethylGene Inc – Pipeline Products Glance 13 MethylGene Inc Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 MethylGene Inc – Early Stage Pipeline Products 15 Pre-Clinical Products/Combination Treatment Modalities 15 MethylGene Inc – Drug Profiles 16 Kinase Inhibitors Program 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 MG-516 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 MG-96077 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 MGCD-265 19 Product Description 19 Mechanism of Action 19 R&D Progress 19
  • 3. MGCD-265 + Docetaxel 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 MGCD-265 + Erlotinib 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 MGCD-290 24 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 IMMUNOMEDICS, INC – Product Pipeline Review – 2012 Ipsen Inc. – Product Pipeline Review – 2012 MerLion Pharmaceuticals Pte Ltd – Product Pipeline Review – 2012 MethylGene Inc – Product Pipeline Review – 2012 Inovio Pharmaceuticals, Inc. – Product Pipeline Review – 2012
  • 4. MOLOGEN AG – Product Pipeline Review – 2012 MorphoSys AG – Product Pipeline Review – 2012 Oncogenex Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Onyx Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Phytopharm Plc – Product Pipeline Review – 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com